Delphi Diagnostics

Oncomark

This company develops prognostic tests for breast cancer patients to help clinicians determine the necessity of chemotherapy treatment.

Oxford Cancer Biomarkers

This company develops and commercialises precision diagnostic tests and digital pathology tools to help clinicians personalise cancer treatment and assess patient toxicity risks.

Delfi Diagnostics

This company develops blood-based liquid biopsy tests for early cancer detection and treatment monitoring for healthcare providers, health systems, and biopharmaceutical partners.

Veracyte

This company develops genomic tests and diagnostic tools to help clinicians and patients make informed treatment decisions for various types of cancer.

Predicta Biosciences

This company develops blood-based genomic diagnostic tests for clinicians and pharmaceutical partners to monitor and treat blood cancers.

Digistain

This company develops a diagnostic test using infrared spectroscopy to provide breast cancer recurrence-risk stratification for oncologists and multidisciplinary clinical teams.

SkylineDx

This company develops molecular diagnostic tests to help healthcare professionals personalise treatment decisions for patients with oncology and inflammatory diseases.

Astron Health

This company develops a precision oncology platform that provides molecular data analysis and personalised treatment reports for cancer patients and their clinicians.